News tagged with hiv drugs
Related topics: hiv
(AP) -- A pill that has long been used to treat HIV has moved one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS.
HIV & AIDS May 08, 2012 | not rated yet | 0
Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".
Medications May 04, 2012 | 4.9 / 5 (9) | 0
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Tr ...
HIV & AIDS May 02, 2012 | 5 / 5 (1) | 0
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens ...
HIV & AIDS May 02, 2012 | not rated yet | 0 |
In early results of a large-scale randomized study published in 2010 and led by researchers from the University of North Carolina at Chapel Hill, giving daily antiretroviral drugs (ART) to HIV-infected moms ...
HIV & AIDS Apr 25, 2012 | not rated yet | 0 |
California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.
HIV & AIDS Apr 23, 2012 | not rated yet | 0
Voluntary testing and counseling (VT/C) for HIV or sexually transmitted infections (STI) among cocaine and heroin users who were treated in the emergency department (ED), accompanied by referral to drug treatment, was associated ...
Addiction Apr 17, 2012 | not rated yet | 0
A once-a-day pill to help prevent HIV infection could significantly reduce the spread of AIDS, but only makes economic sense if used in select, high-risk groups, Stanford University researchers conclude in a new study.
HIV & AIDS Apr 16, 2012 | not rated yet | 0 |
French pharmaceutical giant Sanofi has signed a partnership with India's Hetero to manufacture cheap anti-HIV drugs in South Africa, the company said on Friday.
Medications Mar 30, 2012 | not rated yet | 0
A study in this week's PLoS Medicine suggests that when people are first infected with HIV (primary HIV infection), temporary treatment with antiretroviral drugs (cART) for 24 weeks can delay the need to restart treatment during ...
HIV & AIDS Mar 27, 2012 | not rated yet | 0
Researchers from Boston University School of Medicine (BUSM) and Fenway Health have found that highly active antiretroviral therapy (HAART) does not completely suppress HIV in the semen of sexually active HIV-infected men ...
HIV & AIDS Mar 27, 2012 | 3 / 5 (1) | 0
(HealthDay) -- For patients with HIV-associated Kaposi's sarcoma (HIV-KS), bevacizumab is tolerated and induces a response in some patients, according to a study published online March 19 in the Journal of ...
Cancer Mar 20, 2012 | not rated yet | 0
Russia in 2011 saw a rise of five percent in the number of new HIV infections to 62,000 cases amid worrying signs that heterosexuals and women are increasingly at risk, its chief doctor said Monday.
HIV & AIDS Mar 12, 2012 | not rated yet | 0
A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.
HIV & AIDS Mar 08, 2012 | 4.8 / 5 (5) | 0
Using human immune system cells in the lab, AIDS experts at Johns Hopkins have figured out a way to kill off latent forms of HIV that hide in infected T cells long after antiretroviral therapy has successfully stalled viral ...
Immunology Mar 08, 2012 | 5 / 5 (2) | 0 |